SlideShare a Scribd company logo
1 of 31
TOKSIKOLOGI OBATTOKSIKOLOGI OBAT
OBAT YG SERINGOBAT YG SERING
MENYEBABKAN KERACUNANMENYEBABKAN KERACUNAN
 ANTIHISTAMINANTIHISTAMIN
 ANALGETIKAANALGETIKA
 VITAMIN, MINERALVITAMIN, MINERAL
 OBAT FLUOBAT FLU
 HORMONHORMON
 ANTIBIOTIK INTERNALANTIBIOTIK INTERNAL
NONO KRITERIA TOKSIKKRITERIA TOKSIK DOSISDOSIS
11 PRAKTIS NON TOKSIKPRAKTIS NON TOKSIK > 15 G/KG BB> 15 G/KG BB
22 SEDIKIT TOKSIKSEDIKIT TOKSIK 5 – 15 G/KG BB5 – 15 G/KG BB
33 TOKSISITAS SEDANGTOKSISITAS SEDANG 0,5 – 5 G/KG BB0,5 – 5 G/KG BB
44 SANGAT TOKSIKSANGAT TOKSIK 50-500 MG/KG BB50-500 MG/KG BB
55 TOKSIK EKSTREMTOKSIK EKSTREM 5-50 MG/KG BB5-50 MG/KG BB
66 SUPER TOKSIKSUPER TOKSIK < 5 MG/KG BB< 5 MG/KG BB
INDEKS TERAPIINDEKS TERAPI = LD 50 / ED 50= LD 50 / ED 50
MAKINMAKIN BESARBESAR MAKINMAKIN AMANAMAN
URUTAN TOKSISITAS DITINJAU DARIURUTAN TOKSISITAS DITINJAU DARI
RUTE PEMBERIAN:RUTE PEMBERIAN:
IV > INHALASI > IP > SC > IM > INTRAIV > INHALASI > IP > SC > IM > INTRA
DERMAL > ORAL > TOPIKALDERMAL > ORAL > TOPIKAL
EFEKEFEK
TOKSISITASTOKSISITAS
OBATOBAT
EMESISEMESIS SALISILATSALISILAT
KONSTIPASIKONSTIPASI NARKOTIKANARKOTIKA
BRADICARDIBRADICARDI NARKOTIKA, SEDATIVENARKOTIKA, SEDATIVE
TACHICARDITACHICARDI AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN,
SALISILAT, KOKAINSALISILAT, KOKAIN
MULUT KERINGMULUT KERING AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN,
ANTIHISTAMIN,ANTIHISTAMIN,
NARKOTIKNARKOTIK
ATAKSIAATAKSIA BARBITURAT, FENITOIN,BARBITURAT, FENITOIN,
HALUSINOGENHALUSINOGEN
KOMA, DEPRESIKOMA, DEPRESI A.HISTAMIN, A.PSIKOTIKA.HISTAMIN, A.PSIKOTIK
PENANGANAN KERACUNANPENANGANAN KERACUNAN
PENILAIANPENILAIAN
 FUNGSI RESPIRASIFUNGSI RESPIRASI
 FUNGSI KARDIOVASKULARFUNGSI KARDIOVASKULAR
 GEJALA SSPGEJALA SSP
 GEJALA LAINGEJALA LAIN
 PENENTUAN KERACUANANPENENTUAN KERACUANAN
FAKTOR YGFAKTOR YG
MEMPENGARUHIMEMPENGARUHI
TOKSISITASTOKSISITAS
 KOMPOSISIKOMPOSISI
 DOSISDOSIS
 RUTE PEMBERIANRUTE PEMBERIAN
 METABOLISME TOKSIKMETABOLISME TOKSIK
 KONDISI KESEHATANKONDISI KESEHATAN
 USIA KEMATANGANUSIA KEMATANGAN
 KONDISI NUTRISIKONDISI NUTRISI
 GENETIKGENETIK
 KELAMINKELAMIN
 LINGKUNGANLINGKUNGAN
FAKTOR YANG MENENTUKANFAKTOR YANG MENENTUKAN
TOKSISITASTOKSISITAS
LD 50LD 50
EFEK SAMPINGEFEK SAMPING
KECEPATAN TIMBULNYA EFEKKECEPATAN TIMBULNYA EFEK
CARA PENANGANANCARA PENANGANAN
 PENCUCIAN/LAVAGEPENCUCIAN/LAVAGE
 EMESISEMESIS
 ADSORBENTADSORBENT
 KATARTIKKATARTIK
 DEMULSENDEMULSEN
 DEKONTAMINASI TOPIKALDEKONTAMINASI TOPIKAL
 MENINGKATKAN ELIMINASI ZAT TOKSIKMENINGKATKAN ELIMINASI ZAT TOKSIK
 ANTIDOTANTIDOT
PENCUCIANPENCUCIAN
JK RACUN HRS SGR DIKELUATKAN DRJK RACUN HRS SGR DIKELUATKAN DR
LAMBUNGLAMBUNG
INDIKASIINDIKASI
 1010TIDAK SADAR/SETENGAH SADARTIDAK SADAR/SETENGAH SADAR
 REFLEKS MENELAN HILANG:REFLEKS MENELAN HILANG:
S.IPECAC TIDAK BISAS.IPECAC TIDAK BISA
 SANGAT TOKSIK & BANYAKSANGAT TOKSIK & BANYAK
KI :ZAT KOROSIFKI :ZAT KOROSIF
PASIEN KEJANGPASIEN KEJANG
CAIRAN PENCUCIANCAIRAN PENCUCIAN
 NaHCO3NaHCO3
 Larutan Garam CaLarutan Garam Ca
 Larutan As.TanatLarutan As.Tanat
 KMNO4KMNO4
 NaCl FisiologisNaCl Fisiologis
 AirAir
EMESISEMESIS
JK RACUN MASIH DI SAL CERNAJK RACUN MASIH DI SAL CERNA
SIRUP IPECACSIRUP IPECAC
APOMORFINAPOMORFIN
ALTERNATIF LAINALTERNATIF LAIN
LARUTAN SABUNLARUTAN SABUN
RANGSANGAN MEKANIKRANGSANGAN MEKANIK
KI:KI: OBAT KONVULSANOBAT KONVULSAN
TDK SADAR/REFLEKS MENELAN –TDK SADAR/REFLEKS MENELAN –
PENYAKIT CARDIOVASKULARPENYAKIT CARDIOVASKULAR
EMPISEMAEMPISEMA
ADSORBENADSORBEN
JK RACUN DPT DIABS D/ ABSORBENJK RACUN DPT DIABS D/ ABSORBEN
 KARBON AKTIFKARBON AKTIF
 KAOLINKAOLIN
 PEKTINPEKTIN
 ATALPUGITATALPUGIT
 KOLESTIRAMINKOLESTIRAMIN
ABSORBSI < :TOLBUTAMID, ZAT TDKABSORBSI < :TOLBUTAMID, ZAT TDK
LRT AIRLRT AIR
KATARTIK
JK DIDUGA ZAT TOKSIK SDH MSK USUS
 MgSO4
 Mg SITRAT
 Na SULFAT
 Na FOSFAT
 SORBITOL
 Sbg pencahar
DEMULSEN
• ES KRIM
• SUSU
• PUTIH TELUR
 Lapisi muk zat
racun yg korosif
DEKONTAMINASI
TOPIKAL
• AIR
• SABUN
 u/ zat iritan
PENINGKATAN ELIMINASIPENINGKATAN ELIMINASI
 DIURETIK KUATDIURETIK KUAT
 Yg dpt dikeluarkan diuretik kuatYg dpt dikeluarkan diuretik kuat
amfetamin,penicillin,salisilat,sulfonamidaamfetamin,penicillin,salisilat,sulfonamida
KI : ACETAMINOPHEN,FENOTIAZINKI : ACETAMINOPHEN,FENOTIAZIN
A.DEPRESSAN TRISIKLIK,barbiturat krjA.DEPRESSAN TRISIKLIK,barbiturat krj
pendekpendek
**DIALISISDIALISIS
*PENGASAMAN/PEMBASAAN URIN*PENGASAMAN/PEMBASAAN URIN
ANTIDOTANTIDOT
 KIMIAKIMIA
 RESEPTORRESEPTOR
 DISPOSIONALDISPOSIONAL
 FUNGSIONAL/FISIOLOGISFUNGSIONAL/FISIOLOGIS
 ANTIDOTANTIDOT
ATROPIN----------------ATROPIN----------------
DIAZEPAM--------------DIAZEPAM--------------
DEKTROSE-------------DEKTROSE-------------
ADRENALIN------------ADRENALIN------------
DOPAMIN---------------DOPAMIN---------------
NALOKSON-------------NALOKSON-------------
NITROPRUSID---------NITROPRUSID---------
--
PROTAMIN SULFAT--PROTAMIN SULFAT--
VIT K-----------------VIT K-----------------
ASETILASETIL
SISTEIN-----SISTEIN-----
 RACUN/GEJALARACUN/GEJALA
KOLINESTERASE INHKOLINESTERASE INH
STIMULAN SSPSTIMULAN SSP
HIPOGLIKEMIKHIPOGLIKEMIK
ANAPHYLAKSIISANAPHYLAKSIIS
HIPOTENSIHIPOTENSI
OPIOIDOPIOID
HIPERTENSIHIPERTENSI
HEPARINHEPARIN
ANTIKOAGULANORALANTIKOAGULANORAL
ACHETAMINOPHENACHETAMINOPHEN
KERACUNAN ACETAMINOPHEN
 MK: METABOLIT REAKTIF IK SEL
NECROSIS
HB MET HB(TDK IK O2)
O2
PAR
HB
(ENZ MET HB REDUKTASE)
KOFAKTOR : GLUTATION
• AnjAnj  nekrosis hepatiknekrosis hepatik
• KucKuc Met HemoglobinemiaMet Hemoglobinemia
DOSIS TOKSIKDOSIS TOKSIK
ANJ : 150 MG/KGANJ : 150 MG/KG
KUC : 50 MG/KGKUC : 50 MG/KG
(DOSIS AN: 80 MG(DOSIS AN: 80 MG
REG: 325-500MG)REG: 325-500MG)
GEJALAGEJALA
► ANJ: - DEPRESIANJ: - DEPRESI
- MUNTAH- MUNTAH
- SKT ABD- SKT ABD
- URIN,SERUM: GELAP- URIN,SERUM: GELAP
- MATI ( 2-5 HR)- MATI ( 2-5 HR)
► KUCKUC
- ANOREKSI,SALIVASI,VOMIT- ANOREKSI,SALIVASI,VOMIT
- DEPRESI- DEPRESI
- METHBNEMIA, HEMOGLOBINURIA- METHBNEMIA, HEMOGLOBINURIA
- MEMBRAN CYANOTIK- MEMBRAN CYANOTIK
- URIN, DARAH GELAP- URIN, DARAH GELAP
- WAJAH EDEMA- WAJAH EDEMA
- MATI 18-36 J- MATI 18-36 J
 PROGNOSIS: JELEKPROGNOSIS: JELEK
 TREATMENTTREATMENT
- <4J: EMESIS, GASTRIC LAVAGE,- <4J: EMESIS, GASTRIC LAVAGE,
ACTIVATED CHARCOALACTIVATED CHARCOAL
KUC: YOHIMBINKUC: YOHIMBIN
ANJ: APOMORPHINANJ: APOMORPHIN
-GROUP SULFHYDRYL:N--GROUP SULFHYDRYL:N-
ACETILCYSTEINE 140 MG/KGACETILCYSTEINE 140 MG/KG
- VIT C- VIT C
- SUPPORTIVE THERAPY- SUPPORTIVE THERAPY
-INFUSE : DECTROSE 2,5%-INFUSE : DECTROSE 2,5%
-OXYGEN:-OXYGEN:
-TRANSFUSI DRH-TRANSFUSI DRH
ASPIRIN TOXICOSISASPIRIN TOXICOSIS
 KUC > SERING DRPD ANJKUC > SERING DRPD ANJ
C/ KUC:DEF/AKTC/ KUC:DEF/AKT GLUCORONYLGLUCORONYL
TRANSFERASETRANSFERASE <<
(GT : DETOX & EKS ASPIRIN)(GT : DETOX & EKS ASPIRIN)
EFEK TOKSIK:EFEK TOKSIK:
- TEKAN SUTUL- TEKAN SUTUL
- HAMB AGREGASI TROMBOSIT- HAMB AGREGASI TROMBOSIT
- METABOLIC ACIDOSIS- METABOLIC ACIDOSIS
- RENAL DISEASE- RENAL DISEASE
- GASTRIC ULCERASI- GASTRIC ULCERASI
DOSIS TOXIC:DOSIS TOXIC:
- ANJ : 30 MG /KG/HR- ANJ : 30 MG /KG/HR
- KUC : 25 MG/KG/HR- KUC : 25 MG/KG/HR
(ANAK : 81 MG(ANAK : 81 MG
REG : 325- 500 MG)REG : 325- 500 MG)
GJL:-AKUT:GJL:-AKUT:
DEPRESI, ANOREKSI,DEPRESI, ANOREKSI,
HIPERPIREXIA, VOMIT,HIPERPIREXIA, VOMIT,
ATAKSIA,ATAKSIA,
COMA, MATICOMA, MATI
 KRONIK:KRONIK:
GASTRIK ULCER, PERFORASI,GASTRIK ULCER, PERFORASI,
HEPATOTIKSIK, SUPRESI SUTULHEPATOTIKSIK, SUPRESI SUTUL
TREATMENTTREATMENT
1. 6-12 J : EMETIK,GASTREK1. 6-12 J : EMETIK,GASTREK
LAVAGE,LAVAGE,
ACT CHARCOAL, SALINEACT CHARCOAL, SALINE
CATARTIKCATARTIK
2. DIURESIS : DIURETIK KUAT2. DIURESIS : DIURETIK KUAT
IBUPROFENIBUPROFEN
 NSAID YG TDK DIREKOMENDASI UTKNSAID YG TDK DIREKOMENDASI UTK
PETSPETS  IT SEMPITIT SEMPIT
 TOKSISITAS:TOKSISITAS:
- 150 mg/kg- 150 mg/kg vomit, gastric ulcervomit, gastric ulcer
- 300 mg/kg- 300 mg/kg  ggl ginjalggl ginjal
 PROG : JLKPROG : JLK
 TREAT: 1. EMETIK, GASTRIK L, ATREAT: 1. EMETIK, GASTRIK L, A
CHARCOALCHARCOAL
2. support: infus, diuresis2. support: infus, diuresis
3. simpt: sucralfat, ranitidin,3. simpt: sucralfat, ranitidin,
misotrostolmisotrostol g.ulcerg.ulcer
ANTICOAGULANT
 MK : -INH ENZ PD SINTESIS VIT K
- INH FACT COAG PROD VIT K
 TOXIC DOSE
* ANJ : 5-300 MG/KG
(1-5 MG/KG/HR 5-15 HR)
* KUC: 5-30 MG/KG
(1 MG/KG/HR 5 HR)
 GJL:- DEPRESI,LEMAH
- HEMATEMESIS,HEMATURIA,HEMORRHAGE
- MATI HEMORRHAGE D/PLEURAL CAVITY
 DX:-HISTORY
- SCREENING KOAG: BLEEDING TIME, COAG TIME
- ANALISIS A.COAG KIMIA
• TREATMENT
1. INDUKSI EMESIS, GASTRIC LAVAGE, ACTIVED
CHATCOAL, CATHARTIC
2. ANTIDOTE: VIT K
3. TREAT CLINICAL SIGN
- INTRAPULMONARY HEMORRHAGE:
TRANSFUSI PLASMA, O2, TDK BOLEH
DIBERI FUROSEMIDE INH FS PLATELET
- HIPOVOLEMIC SHOCK: INFUSE,TRANSF
DRH, KORTICOSTEROID,
A.HISTAMIN&DECONGESTAN
 DX: SEJARAH PSEUDOEPHEDRIN,
(PHENYLPROPANOLAMINE)/PPA,DIPHENH
YDRAMINE, CHLORPHENIRAMINE
 GJL:- DEPRESI, GG RESP,
- HIPEREXCITABILITY
- TREMOR, SEIZURES, HIPERACTIVITY
- VOMIT, MIDRIASIS, HIPERTERMIA
- DISORIENTASI
- BRADICARD/TACHICARD
 PROG: BAIK
 TREAT:
1. < 1 J INTAKEEMESIS
2. ACTIVATED CHARCOAL
3. SUPPORTIVE: INFUSE, O2
4. OBAT SEDATIVE HIPERACVTIVE
(DIAZEPAM,PHENOBARBITAL)
5. PROPANOLOLTACHYCARDI
6. ATROPINE BRADYCARD

More Related Content

What's hot

Interaksi obat
Interaksi obat Interaksi obat
Interaksi obat Dedi Kun
 
Biofarmasetika ( i ) new2
Biofarmasetika ( i ) new2Biofarmasetika ( i ) new2
Biofarmasetika ( i ) new2husnul khotimah
 
Sistem penghantaran obat tubuh
Sistem penghantaran obat tubuhSistem penghantaran obat tubuh
Sistem penghantaran obat tubuhMolinda Damris
 
Pelayanan Informasi Obat (PIO)
Pelayanan Informasi Obat (PIO)Pelayanan Informasi Obat (PIO)
Pelayanan Informasi Obat (PIO)Gilang Rizki
 
Farmakologi (prinsip terapeutika) bagian ii
Farmakologi  (prinsip terapeutika) bagian iiFarmakologi  (prinsip terapeutika) bagian ii
Farmakologi (prinsip terapeutika) bagian iiSurya Amal
 
Pemantauan Terapi Obat
Pemantauan Terapi ObatPemantauan Terapi Obat
Pemantauan Terapi Obatnisha althaf
 
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptx
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptxPERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptx
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptxArifin Hidayat
 
Model Kompartemen Farmakokinetika.ppt
Model Kompartemen Farmakokinetika.pptModel Kompartemen Farmakokinetika.ppt
Model Kompartemen Farmakokinetika.pptFazaayuFadhillah
 
Distribusi Obat Dalam Tubuh
Distribusi Obat Dalam TubuhDistribusi Obat Dalam Tubuh
Distribusi Obat Dalam TubuhLilik Sholeha
 
penggolongan obat menurut pemerintah
 penggolongan obat menurut pemerintah penggolongan obat menurut pemerintah
penggolongan obat menurut pemerintahGdiss Yogaswara
 
PENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKPENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKSurya Amal
 
Prinsip kerja Obat
Prinsip kerja ObatPrinsip kerja Obat
Prinsip kerja ObatDokter Tekno
 

What's hot (20)

Interaksi obat
Interaksi obat Interaksi obat
Interaksi obat
 
Biofarmasetika ( i ) new2
Biofarmasetika ( i ) new2Biofarmasetika ( i ) new2
Biofarmasetika ( i ) new2
 
Sistem penghantaran obat tubuh
Sistem penghantaran obat tubuhSistem penghantaran obat tubuh
Sistem penghantaran obat tubuh
 
Pengenalan resep
Pengenalan resepPengenalan resep
Pengenalan resep
 
Pelayanan Informasi Obat (PIO)
Pelayanan Informasi Obat (PIO)Pelayanan Informasi Obat (PIO)
Pelayanan Informasi Obat (PIO)
 
Farmakologi (prinsip terapeutika) bagian ii
Farmakologi  (prinsip terapeutika) bagian iiFarmakologi  (prinsip terapeutika) bagian ii
Farmakologi (prinsip terapeutika) bagian ii
 
Pemantauan Terapi Obat
Pemantauan Terapi ObatPemantauan Terapi Obat
Pemantauan Terapi Obat
 
Obat saluran pencernaan
Obat saluran pencernaanObat saluran pencernaan
Obat saluran pencernaan
 
Antiinflamasi
AntiinflamasiAntiinflamasi
Antiinflamasi
 
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptx
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptxPERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptx
PERHITUNGAN DOSIS OBAT KELOMPOK 5 FARMAKO.pptx
 
Model Kompartemen Farmakokinetika.ppt
Model Kompartemen Farmakokinetika.pptModel Kompartemen Farmakokinetika.ppt
Model Kompartemen Farmakokinetika.ppt
 
Distribusi Obat Dalam Tubuh
Distribusi Obat Dalam TubuhDistribusi Obat Dalam Tubuh
Distribusi Obat Dalam Tubuh
 
penggolongan obat menurut pemerintah
 penggolongan obat menurut pemerintah penggolongan obat menurut pemerintah
penggolongan obat menurut pemerintah
 
PENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKPENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIK
 
Naranjo naranjo
Naranjo naranjoNaranjo naranjo
Naranjo naranjo
 
Pertemuan 1 cpob (tek.solid)
Pertemuan 1 cpob (tek.solid)Pertemuan 1 cpob (tek.solid)
Pertemuan 1 cpob (tek.solid)
 
Prinsip kerja Obat
Prinsip kerja ObatPrinsip kerja Obat
Prinsip kerja Obat
 
2. sistem pencernaan
2. sistem pencernaan2. sistem pencernaan
2. sistem pencernaan
 
Farmakologi cara pemberian obat
Farmakologi cara pemberian obatFarmakologi cara pemberian obat
Farmakologi cara pemberian obat
 
Fitofarmaka
FitofarmakaFitofarmaka
Fitofarmaka
 

Similar to TOKSIKOLOGI OBAT

Pituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic managementPituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic managementUnnikrishnan Prathapadas
 
5. pharma musculoskeletal system
5. pharma musculoskeletal system5. pharma musculoskeletal system
5. pharma musculoskeletal systemjhonee balmeo
 
Newer drugs in management of glaucoma
Newer drugs in management of glaucomaNewer drugs in management of glaucoma
Newer drugs in management of glaucomaDrArvindMorya
 
COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....V467
 
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritisDisease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritisBipulBorthakur
 
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda JainOBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda JainLifecare Centre
 
Osteoporosis treatment & surgical significance
Osteoporosis  treatment & surgical significanceOsteoporosis  treatment & surgical significance
Osteoporosis treatment & surgical significanceVinoth Kumar
 
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptxDIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptxsubhayan999
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfnajmishafiz
 
Respiratory illness treatment
Respiratory illness treatmentRespiratory illness treatment
Respiratory illness treatmentKamal Sharma
 
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttxHYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttxtiti224002
 
Corticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptxCorticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptxSiddharthSingh639
 
Factors affecting drug action pdf
Factors affecting drug action pdfFactors affecting drug action pdf
Factors affecting drug action pdfAarushiSharma54
 
Drugs for neutropenia
Drugs for neutropeniaDrugs for neutropenia
Drugs for neutropeniaDeepak Anand
 

Similar to TOKSIKOLOGI OBAT (20)

Pituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic managementPituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic management
 
5. pharma musculoskeletal system
5. pharma musculoskeletal system5. pharma musculoskeletal system
5. pharma musculoskeletal system
 
Steroids ppt
Steroids pptSteroids ppt
Steroids ppt
 
Newer drugs in management of glaucoma
Newer drugs in management of glaucomaNewer drugs in management of glaucoma
Newer drugs in management of glaucoma
 
COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....
 
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritisDisease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
 
CASE STUDY GERD
CASE STUDY GERDCASE STUDY GERD
CASE STUDY GERD
 
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda JainOBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
 
Osteoporosis treatment & surgical significance
Osteoporosis  treatment & surgical significanceOsteoporosis  treatment & surgical significance
Osteoporosis treatment & surgical significance
 
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptxDIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
 
Respiratory illness treatment
Respiratory illness treatmentRespiratory illness treatment
Respiratory illness treatment
 
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttxHYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
 
Corticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptxCorticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptx
 
Hemostatika
HemostatikaHemostatika
Hemostatika
 
Factors affecting drug action pdf
Factors affecting drug action pdfFactors affecting drug action pdf
Factors affecting drug action pdf
 
Drugs for neutropenia
Drugs for neutropeniaDrugs for neutropenia
Drugs for neutropenia
 
Dr tarek NSAIDs
Dr tarek NSAIDsDr tarek NSAIDs
Dr tarek NSAIDs
 
Anti emetic models
Anti emetic modelsAnti emetic models
Anti emetic models
 
Hyperandrogenism
HyperandrogenismHyperandrogenism
Hyperandrogenism
 

Recently uploaded

AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdfAWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdfSkillCertProExams
 
Dreaming Marissa Sánchez Music Video Treatment
Dreaming Marissa Sánchez Music Video TreatmentDreaming Marissa Sánchez Music Video Treatment
Dreaming Marissa Sánchez Music Video Treatmentnswingard
 
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...David Celestin
 
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...amilabibi1
 
Digital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of DrupalDigital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of DrupalFabian de Rijk
 
Uncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac FolorunsoUncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac FolorunsoKayode Fayemi
 
Report Writing Webinar Training
Report Writing Webinar TrainingReport Writing Webinar Training
Report Writing Webinar TrainingKylaCullinane
 
My Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle BaileyMy Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle Baileyhlharris
 
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptx
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptxChiulli_Aurora_Oman_Raffaele_Beowulf.pptx
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptxraffaeleoman
 
If this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New NigeriaIf this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New NigeriaKayode Fayemi
 
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdfSOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdfMahamudul Hasan
 
lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.lodhisaajjda
 
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdfThe workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdfSenaatti-kiinteistöt
 
Dreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio IIIDreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio IIINhPhngng3
 

Recently uploaded (15)

AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdfAWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
 
Dreaming Marissa Sánchez Music Video Treatment
Dreaming Marissa Sánchez Music Video TreatmentDreaming Marissa Sánchez Music Video Treatment
Dreaming Marissa Sánchez Music Video Treatment
 
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
 
ICT role in 21st century education and it's challenges.pdf
ICT role in 21st century education and it's challenges.pdfICT role in 21st century education and it's challenges.pdf
ICT role in 21st century education and it's challenges.pdf
 
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...
Bring back lost lover in USA, Canada ,Uk ,Australia ,London Lost Love Spell C...
 
Digital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of DrupalDigital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of Drupal
 
Uncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac FolorunsoUncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac Folorunso
 
Report Writing Webinar Training
Report Writing Webinar TrainingReport Writing Webinar Training
Report Writing Webinar Training
 
My Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle BaileyMy Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle Bailey
 
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptx
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptxChiulli_Aurora_Oman_Raffaele_Beowulf.pptx
Chiulli_Aurora_Oman_Raffaele_Beowulf.pptx
 
If this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New NigeriaIf this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New Nigeria
 
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdfSOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
 
lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.
 
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdfThe workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
 
Dreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio IIIDreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio III
 

TOKSIKOLOGI OBAT

  • 2. OBAT YG SERINGOBAT YG SERING MENYEBABKAN KERACUNANMENYEBABKAN KERACUNAN  ANTIHISTAMINANTIHISTAMIN  ANALGETIKAANALGETIKA  VITAMIN, MINERALVITAMIN, MINERAL  OBAT FLUOBAT FLU  HORMONHORMON  ANTIBIOTIK INTERNALANTIBIOTIK INTERNAL
  • 3. NONO KRITERIA TOKSIKKRITERIA TOKSIK DOSISDOSIS 11 PRAKTIS NON TOKSIKPRAKTIS NON TOKSIK > 15 G/KG BB> 15 G/KG BB 22 SEDIKIT TOKSIKSEDIKIT TOKSIK 5 – 15 G/KG BB5 – 15 G/KG BB 33 TOKSISITAS SEDANGTOKSISITAS SEDANG 0,5 – 5 G/KG BB0,5 – 5 G/KG BB 44 SANGAT TOKSIKSANGAT TOKSIK 50-500 MG/KG BB50-500 MG/KG BB 55 TOKSIK EKSTREMTOKSIK EKSTREM 5-50 MG/KG BB5-50 MG/KG BB 66 SUPER TOKSIKSUPER TOKSIK < 5 MG/KG BB< 5 MG/KG BB
  • 4. INDEKS TERAPIINDEKS TERAPI = LD 50 / ED 50= LD 50 / ED 50 MAKINMAKIN BESARBESAR MAKINMAKIN AMANAMAN URUTAN TOKSISITAS DITINJAU DARIURUTAN TOKSISITAS DITINJAU DARI RUTE PEMBERIAN:RUTE PEMBERIAN: IV > INHALASI > IP > SC > IM > INTRAIV > INHALASI > IP > SC > IM > INTRA DERMAL > ORAL > TOPIKALDERMAL > ORAL > TOPIKAL
  • 5. EFEKEFEK TOKSISITASTOKSISITAS OBATOBAT EMESISEMESIS SALISILATSALISILAT KONSTIPASIKONSTIPASI NARKOTIKANARKOTIKA BRADICARDIBRADICARDI NARKOTIKA, SEDATIVENARKOTIKA, SEDATIVE TACHICARDITACHICARDI AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN, SALISILAT, KOKAINSALISILAT, KOKAIN MULUT KERINGMULUT KERING AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN, ANTIHISTAMIN,ANTIHISTAMIN, NARKOTIKNARKOTIK ATAKSIAATAKSIA BARBITURAT, FENITOIN,BARBITURAT, FENITOIN, HALUSINOGENHALUSINOGEN KOMA, DEPRESIKOMA, DEPRESI A.HISTAMIN, A.PSIKOTIKA.HISTAMIN, A.PSIKOTIK
  • 6. PENANGANAN KERACUNANPENANGANAN KERACUNAN PENILAIANPENILAIAN  FUNGSI RESPIRASIFUNGSI RESPIRASI  FUNGSI KARDIOVASKULARFUNGSI KARDIOVASKULAR  GEJALA SSPGEJALA SSP  GEJALA LAINGEJALA LAIN  PENENTUAN KERACUANANPENENTUAN KERACUANAN
  • 7. FAKTOR YGFAKTOR YG MEMPENGARUHIMEMPENGARUHI TOKSISITASTOKSISITAS  KOMPOSISIKOMPOSISI  DOSISDOSIS  RUTE PEMBERIANRUTE PEMBERIAN  METABOLISME TOKSIKMETABOLISME TOKSIK  KONDISI KESEHATANKONDISI KESEHATAN  USIA KEMATANGANUSIA KEMATANGAN  KONDISI NUTRISIKONDISI NUTRISI  GENETIKGENETIK  KELAMINKELAMIN  LINGKUNGANLINGKUNGAN
  • 8. FAKTOR YANG MENENTUKANFAKTOR YANG MENENTUKAN TOKSISITASTOKSISITAS LD 50LD 50 EFEK SAMPINGEFEK SAMPING KECEPATAN TIMBULNYA EFEKKECEPATAN TIMBULNYA EFEK
  • 9. CARA PENANGANANCARA PENANGANAN  PENCUCIAN/LAVAGEPENCUCIAN/LAVAGE  EMESISEMESIS  ADSORBENTADSORBENT  KATARTIKKATARTIK  DEMULSENDEMULSEN  DEKONTAMINASI TOPIKALDEKONTAMINASI TOPIKAL  MENINGKATKAN ELIMINASI ZAT TOKSIKMENINGKATKAN ELIMINASI ZAT TOKSIK  ANTIDOTANTIDOT
  • 10. PENCUCIANPENCUCIAN JK RACUN HRS SGR DIKELUATKAN DRJK RACUN HRS SGR DIKELUATKAN DR LAMBUNGLAMBUNG INDIKASIINDIKASI  1010TIDAK SADAR/SETENGAH SADARTIDAK SADAR/SETENGAH SADAR  REFLEKS MENELAN HILANG:REFLEKS MENELAN HILANG: S.IPECAC TIDAK BISAS.IPECAC TIDAK BISA  SANGAT TOKSIK & BANYAKSANGAT TOKSIK & BANYAK
  • 11. KI :ZAT KOROSIFKI :ZAT KOROSIF PASIEN KEJANGPASIEN KEJANG CAIRAN PENCUCIANCAIRAN PENCUCIAN  NaHCO3NaHCO3  Larutan Garam CaLarutan Garam Ca  Larutan As.TanatLarutan As.Tanat  KMNO4KMNO4  NaCl FisiologisNaCl Fisiologis  AirAir
  • 12. EMESISEMESIS JK RACUN MASIH DI SAL CERNAJK RACUN MASIH DI SAL CERNA SIRUP IPECACSIRUP IPECAC APOMORFINAPOMORFIN ALTERNATIF LAINALTERNATIF LAIN LARUTAN SABUNLARUTAN SABUN RANGSANGAN MEKANIKRANGSANGAN MEKANIK KI:KI: OBAT KONVULSANOBAT KONVULSAN TDK SADAR/REFLEKS MENELAN –TDK SADAR/REFLEKS MENELAN – PENYAKIT CARDIOVASKULARPENYAKIT CARDIOVASKULAR EMPISEMAEMPISEMA
  • 13. ADSORBENADSORBEN JK RACUN DPT DIABS D/ ABSORBENJK RACUN DPT DIABS D/ ABSORBEN  KARBON AKTIFKARBON AKTIF  KAOLINKAOLIN  PEKTINPEKTIN  ATALPUGITATALPUGIT  KOLESTIRAMINKOLESTIRAMIN ABSORBSI < :TOLBUTAMID, ZAT TDKABSORBSI < :TOLBUTAMID, ZAT TDK LRT AIRLRT AIR
  • 14. KATARTIK JK DIDUGA ZAT TOKSIK SDH MSK USUS  MgSO4  Mg SITRAT  Na SULFAT  Na FOSFAT  SORBITOL  Sbg pencahar
  • 15. DEMULSEN • ES KRIM • SUSU • PUTIH TELUR  Lapisi muk zat racun yg korosif DEKONTAMINASI TOPIKAL • AIR • SABUN  u/ zat iritan
  • 16. PENINGKATAN ELIMINASIPENINGKATAN ELIMINASI  DIURETIK KUATDIURETIK KUAT  Yg dpt dikeluarkan diuretik kuatYg dpt dikeluarkan diuretik kuat amfetamin,penicillin,salisilat,sulfonamidaamfetamin,penicillin,salisilat,sulfonamida KI : ACETAMINOPHEN,FENOTIAZINKI : ACETAMINOPHEN,FENOTIAZIN A.DEPRESSAN TRISIKLIK,barbiturat krjA.DEPRESSAN TRISIKLIK,barbiturat krj pendekpendek **DIALISISDIALISIS *PENGASAMAN/PEMBASAAN URIN*PENGASAMAN/PEMBASAAN URIN
  • 17. ANTIDOTANTIDOT  KIMIAKIMIA  RESEPTORRESEPTOR  DISPOSIONALDISPOSIONAL  FUNGSIONAL/FISIOLOGISFUNGSIONAL/FISIOLOGIS
  • 18.  ANTIDOTANTIDOT ATROPIN----------------ATROPIN---------------- DIAZEPAM--------------DIAZEPAM-------------- DEKTROSE-------------DEKTROSE------------- ADRENALIN------------ADRENALIN------------ DOPAMIN---------------DOPAMIN--------------- NALOKSON-------------NALOKSON------------- NITROPRUSID---------NITROPRUSID--------- -- PROTAMIN SULFAT--PROTAMIN SULFAT-- VIT K-----------------VIT K----------------- ASETILASETIL SISTEIN-----SISTEIN-----  RACUN/GEJALARACUN/GEJALA KOLINESTERASE INHKOLINESTERASE INH STIMULAN SSPSTIMULAN SSP HIPOGLIKEMIKHIPOGLIKEMIK ANAPHYLAKSIISANAPHYLAKSIIS HIPOTENSIHIPOTENSI OPIOIDOPIOID HIPERTENSIHIPERTENSI HEPARINHEPARIN ANTIKOAGULANORALANTIKOAGULANORAL ACHETAMINOPHENACHETAMINOPHEN
  • 19. KERACUNAN ACETAMINOPHEN  MK: METABOLIT REAKTIF IK SEL NECROSIS HB MET HB(TDK IK O2) O2 PAR HB (ENZ MET HB REDUKTASE) KOFAKTOR : GLUTATION
  • 20.
  • 21. • AnjAnj  nekrosis hepatiknekrosis hepatik • KucKuc Met HemoglobinemiaMet Hemoglobinemia DOSIS TOKSIKDOSIS TOKSIK ANJ : 150 MG/KGANJ : 150 MG/KG KUC : 50 MG/KGKUC : 50 MG/KG (DOSIS AN: 80 MG(DOSIS AN: 80 MG REG: 325-500MG)REG: 325-500MG)
  • 22. GEJALAGEJALA ► ANJ: - DEPRESIANJ: - DEPRESI - MUNTAH- MUNTAH - SKT ABD- SKT ABD - URIN,SERUM: GELAP- URIN,SERUM: GELAP - MATI ( 2-5 HR)- MATI ( 2-5 HR) ► KUCKUC - ANOREKSI,SALIVASI,VOMIT- ANOREKSI,SALIVASI,VOMIT - DEPRESI- DEPRESI - METHBNEMIA, HEMOGLOBINURIA- METHBNEMIA, HEMOGLOBINURIA - MEMBRAN CYANOTIK- MEMBRAN CYANOTIK - URIN, DARAH GELAP- URIN, DARAH GELAP - WAJAH EDEMA- WAJAH EDEMA - MATI 18-36 J- MATI 18-36 J
  • 23.  PROGNOSIS: JELEKPROGNOSIS: JELEK  TREATMENTTREATMENT - <4J: EMESIS, GASTRIC LAVAGE,- <4J: EMESIS, GASTRIC LAVAGE, ACTIVATED CHARCOALACTIVATED CHARCOAL KUC: YOHIMBINKUC: YOHIMBIN ANJ: APOMORPHINANJ: APOMORPHIN -GROUP SULFHYDRYL:N--GROUP SULFHYDRYL:N- ACETILCYSTEINE 140 MG/KGACETILCYSTEINE 140 MG/KG - VIT C- VIT C - SUPPORTIVE THERAPY- SUPPORTIVE THERAPY -INFUSE : DECTROSE 2,5%-INFUSE : DECTROSE 2,5% -OXYGEN:-OXYGEN: -TRANSFUSI DRH-TRANSFUSI DRH
  • 24. ASPIRIN TOXICOSISASPIRIN TOXICOSIS  KUC > SERING DRPD ANJKUC > SERING DRPD ANJ C/ KUC:DEF/AKTC/ KUC:DEF/AKT GLUCORONYLGLUCORONYL TRANSFERASETRANSFERASE << (GT : DETOX & EKS ASPIRIN)(GT : DETOX & EKS ASPIRIN) EFEK TOKSIK:EFEK TOKSIK: - TEKAN SUTUL- TEKAN SUTUL - HAMB AGREGASI TROMBOSIT- HAMB AGREGASI TROMBOSIT - METABOLIC ACIDOSIS- METABOLIC ACIDOSIS - RENAL DISEASE- RENAL DISEASE - GASTRIC ULCERASI- GASTRIC ULCERASI
  • 25. DOSIS TOXIC:DOSIS TOXIC: - ANJ : 30 MG /KG/HR- ANJ : 30 MG /KG/HR - KUC : 25 MG/KG/HR- KUC : 25 MG/KG/HR (ANAK : 81 MG(ANAK : 81 MG REG : 325- 500 MG)REG : 325- 500 MG) GJL:-AKUT:GJL:-AKUT: DEPRESI, ANOREKSI,DEPRESI, ANOREKSI, HIPERPIREXIA, VOMIT,HIPERPIREXIA, VOMIT, ATAKSIA,ATAKSIA, COMA, MATICOMA, MATI
  • 26.  KRONIK:KRONIK: GASTRIK ULCER, PERFORASI,GASTRIK ULCER, PERFORASI, HEPATOTIKSIK, SUPRESI SUTULHEPATOTIKSIK, SUPRESI SUTUL TREATMENTTREATMENT 1. 6-12 J : EMETIK,GASTREK1. 6-12 J : EMETIK,GASTREK LAVAGE,LAVAGE, ACT CHARCOAL, SALINEACT CHARCOAL, SALINE CATARTIKCATARTIK 2. DIURESIS : DIURETIK KUAT2. DIURESIS : DIURETIK KUAT
  • 27. IBUPROFENIBUPROFEN  NSAID YG TDK DIREKOMENDASI UTKNSAID YG TDK DIREKOMENDASI UTK PETSPETS  IT SEMPITIT SEMPIT  TOKSISITAS:TOKSISITAS: - 150 mg/kg- 150 mg/kg vomit, gastric ulcervomit, gastric ulcer - 300 mg/kg- 300 mg/kg  ggl ginjalggl ginjal  PROG : JLKPROG : JLK  TREAT: 1. EMETIK, GASTRIK L, ATREAT: 1. EMETIK, GASTRIK L, A CHARCOALCHARCOAL 2. support: infus, diuresis2. support: infus, diuresis 3. simpt: sucralfat, ranitidin,3. simpt: sucralfat, ranitidin, misotrostolmisotrostol g.ulcerg.ulcer
  • 28. ANTICOAGULANT  MK : -INH ENZ PD SINTESIS VIT K - INH FACT COAG PROD VIT K  TOXIC DOSE * ANJ : 5-300 MG/KG (1-5 MG/KG/HR 5-15 HR) * KUC: 5-30 MG/KG (1 MG/KG/HR 5 HR)  GJL:- DEPRESI,LEMAH - HEMATEMESIS,HEMATURIA,HEMORRHAGE - MATI HEMORRHAGE D/PLEURAL CAVITY  DX:-HISTORY - SCREENING KOAG: BLEEDING TIME, COAG TIME - ANALISIS A.COAG KIMIA
  • 29. • TREATMENT 1. INDUKSI EMESIS, GASTRIC LAVAGE, ACTIVED CHATCOAL, CATHARTIC 2. ANTIDOTE: VIT K 3. TREAT CLINICAL SIGN - INTRAPULMONARY HEMORRHAGE: TRANSFUSI PLASMA, O2, TDK BOLEH DIBERI FUROSEMIDE INH FS PLATELET - HIPOVOLEMIC SHOCK: INFUSE,TRANSF DRH, KORTICOSTEROID,
  • 30. A.HISTAMIN&DECONGESTAN  DX: SEJARAH PSEUDOEPHEDRIN, (PHENYLPROPANOLAMINE)/PPA,DIPHENH YDRAMINE, CHLORPHENIRAMINE  GJL:- DEPRESI, GG RESP, - HIPEREXCITABILITY - TREMOR, SEIZURES, HIPERACTIVITY - VOMIT, MIDRIASIS, HIPERTERMIA - DISORIENTASI - BRADICARD/TACHICARD
  • 31.  PROG: BAIK  TREAT: 1. < 1 J INTAKEEMESIS 2. ACTIVATED CHARCOAL 3. SUPPORTIVE: INFUSE, O2 4. OBAT SEDATIVE HIPERACVTIVE (DIAZEPAM,PHENOBARBITAL) 5. PROPANOLOLTACHYCARDI 6. ATROPINE BRADYCARD